GPT Healthcare Limited has announced a board meeting to review the financial results for the quarter and half-year ended September 30, 2024. The unaudited total income from operations stands at ₹133.09 crore, with a net profit of ₹83.44 crore after tax. The results reflect a recovery following previous losses, indicating improved operational efficiency. Investors may view this as a positive signal, suggesting enhanced financial health and potential future dividends, contributing to a more favorable sentiment towards the stock.